Steven Fineberg, MD, presented the study at the International Society for the Study of Lumbar Spine Meeting.
BMP is used in more than half of the anterior lumbar fusions in the U.S. and about one third of posterior lumbar fusions. Patients receiving the drug are typically younger with fewer comorbidities, according to the report.
More Articles on Devices:
Benvenue Medical Concludes Patient Follow-Ups in Orthopedic Device Clinical Trial
Medtronic to Eliminate 2k Jobs Worldwide
Blue Belt Technologies, DJO Surgical Partner for Knee Implant System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
